Concepedia

Margherita Ambrosini

MA

Statistics

Publications

27

Citations

1.4K

H-Index

20

Active since

2020

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Istituto Oncologico Veneto

Azienda Ospedaliera Universitaria Pisana

Istituti di Ricovero e Cura a Carattere Scientifico

University of Pisa

Margherita Ambrosini is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in oncology, medicine, and colorectal cancer.

ORCID

Publications per year

2020–2025

27

Publications

27

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio et al. · The Lancet Oncology · 2022 · 270 citations · Full text

, , +10

Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial

Andrea Sartore‐Bianchi, Filippo Pietrantonio, Sara Lonardi et al. · Nature Medicine · 2022 · 261 citations · Full text

, , +17

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

Giovanni Fucà, Romain Cohen, Sara Lonardi et al. · Journal for ImmunoTherapy of Cancer · 2022 · 120 citations · Full text

, , +17

The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors

Francesca Corti, Sara Lonardi, Rossana Intini et al. · European Journal of Cancer · 2021 · 109 citations

, , +14

Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer

Margherita Ambrosini, Benoı̂t Rousseau, Paolo Manca et al. · Annals of Oncology · 2024 · 75 citations · Full text

, , +17

1–5 of 27